Company Filing History:
16 out of 559 
9 out of 512 
2 out of 143 
Years Active: 1998-2025
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Stewart Shuman.
Title: The Pioneering Work of Inventor Stewart Shuman
Introduction:
Stewart Shuman is a renowned inventor based in New York, NY (US) who has made significant contributions to the fields of oncology, virology, and immunotherapy. With an impressive portfolio of 29 patents, Shuman's innovative work focuses on utilizing poxviruses for cancer immunotherapy.
Latest Patents:
Shuman's latest patents include groundbreaking inventions such as Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors. This patent explores the use of modified vaccinia virus Ankara (MVA) and recombinant poxviruses for cancer immunotherapy, particularly in combination with immune checkpoint blockade therapy.
Another notable patent is on Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy. This invention showcases the potential of poxviruses for oncolytic and immunotherapy purposes, either in active or inactivated forms.
Career Highlights:
Throughout his career, Stewart Shuman has worked at esteemed institutions such as Memorial Sloan Kettering Cancer Center and Sloan-Kettering Institute for Cancer Research. His dedication to advancing cancer treatment through innovative technologies has led to groundbreaking discoveries in the field of immunotherapy.
Collaborations:
Shuman has collaborated with talented individuals in his field, including Liang Deng and Jedd David Wolchok. These partnerships have been instrumental in the development and implementation of his patented technologies, further solidifying his reputation as a leading figure in the industry.
Conclusion:
In conclusion, Stewart Shuman's pioneering work in oncology, virology, and immunotherapy has significantly impacted the field of cancer treatment. With a diverse range of patents and a steadfast commitment to innovation, Shuman continues to push the boundaries of science and contribute to the development of life-saving therapies.